Clinical manifestations of ocular toxoplasmosis (Q37856265)

24 August 2017

1 reference

title

Clinical manifestations of ocular toxoplasmosis (English)

1 reference

24 August 2017

0 references

Emmanuelle Delair

1

1 reference

24 August 2017

Paul Latkany

2

1 reference

24 August 2017

A Gwendolyn Noble

3

1 reference

24 August 2017

Peter Rabiah

4

1 reference

24 August 2017

Rima McLeod

5

1 reference

24 August 2017

Antoine Brézin

6

1 reference

24 August 2017

1 April 2011

1 reference

Ocular Immunology and Inflammation

24 August 2017

1 reference

24 August 2017

19

1 reference

24 August 2017

91-102

1 reference

24 August 2017

2

1 reference

Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Ocular involvement in toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Why prevent, diagnose and treat congenital toxoplasmosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Cataracts in congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Atypical anterior optic neuropathy caused by toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Branch retinal artery occlusion in toxoplasma retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Retinal detachment in ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Ocular manifestations in congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Long-term ocular prognosis in 327 children with congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Ocular toxoplasmosis--clinical aspect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Recurrent ocular disease in postnatally acquired toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2011.564068

An unusually high prevalence of ocular toxoplasmosis in southern Brazil

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0002-9394(14)73976-5

Identifiers

DOI

10.3109/09273948.2011.564068

1 reference

24 August 2017

1 reference